Loading
รศ.ดร. ศิริรัตน์ อนุตระกูลชัย

รศ.ดร. ศิริรัตน์ อนุตระกูลชัย

ภาควิชาอายุรศาสตร์,
คณะแพทยศาสตร์,
มหาวิทยาลัยขอนแก่น
56479104300: H-INDEX
57196064454: H-INDEX 20
57409968800: H-INDEX 21
57756573400: H-INDEX 1
59150611900: H-INDEX 0
6506392390: H-INDEX 1
6506623795: H-INDEX 21

บทความ

TCI อ้างอิงจาก http://www.tci-thaijo.org/

0

SCOPUS

0

PUBMED

0

ISI

0

TCI

Title Author Year SCOPUS PUBMED ISI TCI
1. The effect of prostaglandin E1 analog misoprostol on chronic cyclosporin nephrotoxicity. John, EG
Fornell, LC
Radhakrishnan, J
Anutrakulchai, S
Jonasson, O
1993
2. Correlation between Na, K-ATPase activity and potassium and magnesium contents in skeletal muscle of renal stone patients Prasongwatana, V.
Tavichakorntrakool, R.
Sriboonlue, P.
Wongkham, C.
Bovornpadungkitti, S.
Premgamone, A.
Reungjuiy, S.
2001
3. Magnesium status of patients with renal stones and its effect on urinary citrate excretion Reungjui, S.
Prasongwatana, V.
Premgamone, A.
Tosukhowong, P.
Jirakulsomchok, S.
Sriboonlue, P.
2002
4. Urinary citrate excretion in patients with renal stone: roles of leucocyte ATP citrate lyase activity and potassium salts therapy. Tosukhowong, P.
Prasongwatana, V.
Tungsanga, K.
Reungjui, S.
Sriboonlue, P.
2002
5. Azathioprine-induced fatal myelosuppression in a renal-transplant recipient who carried heterozygous TPMT*1/*3C Tassaneeyakul, W
Srimarthpirom, S
Reungjui, S
Chansung, K
Romphruk, A
Tassaneeyakul, W
2003
6. Azathioprine-induced fatal myelosuppression in a renal-transplant recipient who carried heterozygous TPMT*1/*3C [4] Tassaneeyakul, W.
Srimarthpirom, S.
Reungjui, S.
Chansung, G.
Romphruk, A.V.
Tassaneeyakul, W.
2003
7. Graft survival analysis in kidney transplantation: a 12-year experience in a Thai medical center. D Sirivongs
W Liawnoraset
C Pongskul
S Reungjui
2004
8. The effects of potassium and magnesium supplementations on urinary risk factors of renal stone patients Jaipakdee, S
Prasongwatana, V
Premgamone, A
Reungjui, S
Tosukhowong, P
Tungsanga, K
Suwantrai, S
Noppawinyoowong, C
Maskasame, S
Sriboonlue, P
2004
9. Ceftazidime overdose-related nonconvulsive status epilepticus after intraperitoneal instillation S Vannaprasaht
A Tawalee
N Mayurasakorn
C Yodwut
R Bansong
S Reungjui
S Tiamkao
2006
10. Uric acid, the metabolic syndrome, and renal disease Cirillo, P
Sato, W
Reungjui, S
Heinig, M
Gersch, M
Sautin, Y
Nakagawa, T
Johnson, RJ
2006
11. Effect of elevated serum uric acid on cisplatin-induced acute renal failure Carlos A. Roncal
Wei Mu
Byron Croker
Sirirat Reungjui
Xiaosen Ouyang
Isabelle Tabah-Fisch
Richard J. Johnson
A. Ahsan Ejaz
2007
12. Effect of reduced renal mass on renal ammonia transporter family, Rh C glycoprotein and Rh B glycoprotein, expression. Hye-Young Kim
Chris Baylis
Jill W. Verlander
Ki-Hwan Han
Sirirat Reungjui
Mary E. Handlogten
I. David Weiner
2007
13. Effects of ischemia-reperfusion injury on renal ammonia metabolism and the collecting duct. Han, K.
Kim, H.
Reungjui, S.
Lee, S.
Kim, J.
Weiner, I.D.
2007
14. Fructose, but not dextrose, accelerates the progression of chronic kidney disease Cirillo, P.
Reungjui, S.
Johnson, R.J.
Nakagawa, T.
2007
15. Lead, at low levels, accelerates arteriolopathy and tubulointerstitial injury in chronic kidney disease Carlos Roncal
Wei Mu
Sirirat Reungjui
Kyung Mee Kim
George N. Henderson
Xiaosen Ouyang
Takahiko Nakagawa
Richard J. Johnson
2007
16. Thiazide diuretics exacerbate fructose-induced metabolic syndrome Sirirat Reungjui
Carlos A. Roncal
Wei Mu
Titte R. Srinivas
Dhavee Sirivongs
Richard J. Johnson
Takahiko Nakagawa
2007
17. Thiazide-induced subtle renal injury not observed in states of equivalent hypokalemia. S. Reungjui
H. Hu
W. Mu
C. A. Roncal
B. P. Croker
J. M. Patel
T. Nakagawa
T. Srinivas
K. Byer
J. Simoni
D. Wesson
V. Sitprija
R. J. Johnson
2007
18. Do thiazides worsen metabolic syndrome and renal disease? The pivotal roles for hyperuricemia and hypokalemia. Sirirat Reungjui
Thongchai Pratipanawatr
Richard J. Johnson
Takahiko Nakagawa
2008
19. Hypokalemic nephropathy is associated with impaired angiogenesis. Reungjui, S.
Sato, W.
Tungsanga, K.
Nakagawa, T.
Johnson, R.J.
2008
20. Response to 'Thiazide diuretics: Rat versus man' Sirirat Reungjui
Richard J. Johnson
2008
21. Combination of captopril and allopurinol retards fructose-induced metabolic syndrome Carlos A. Roncal
Sirirat Reungjui
Laura Gabriela Sanchez-Lozada
Wei Mu
Yuri Y. Sautin
Takahiko Nakagawa
Richard J. Johnson
2009
22. Comparison of free fructose and glucose to sucrose in the ability to cause fatty liver Laura G. Sanchez-Lozada
Wei Mu
Carlos Roncal
Yuri Y. Sautin
Manal Abdelmalek
Sirirat Reungjui
MyPhuong Le
Takahiko Nakagawa
Hui Y. Lan
Xuequing Yu
Richard J. Johnson
2010
23. Disease patterns among Thai adult population: an analysis of data from the hospitalization National Health Insurance System 2010. Anunnatsiri, S.
Reungjui, S.
Thavornpitak, Y.
Mairiang, P.
2012
24. Health insurance system and healthcare provision: nationwide hospital admission data 2010. Reungjui, S.
Anunnatsiri, S.
Limwattananon, C.
Thavornpitak, Y.
Mairiang, P.
2012
25. Monosodium Glutamate (MSG) Consumption Is Associated with Urolithiasis and Urinary Tract Obstruction in Rats Sharma, A.
Prasongwattana, V.
Cha'on, U.
Hipkaeo, W.
Boonnate, P.
Pethlert, S.
Titipungul, T.
Intarawichian, P.
Waraasawapati, S.
Puapiroj, A.
Sitprija, V.
Reungjui, S.
2013
26. Personalized tacrolimus doses determined by CYP3A5 genotype for induction and maintenance phases of kidney transplantation. Suda Vannaprasaht
Sirirat Reungjui
Darika Supanya
Dhavee Sirivongs
Cholatip Pongskul
Yingyos Avihingsanon
Wichittra Tassaneeyakul
2013
27. Dialysis Dose and Risk Factors for Death Among ESRD Patients Treated with Twice-Weekly Hemodialysis: A Prospective Cohort Study Panaput, T
Thinkhamrop, B
Domrongkitchaiporn, S
Sirivongs, D
Praderm, L
Anukulanantachai, J
Kanokkantapong, C
Tungkasereerak, P
Pongskul, C
Anutrakulchai, S
Keobounma, T
Narenpitak, S
Intarawongchot, P
Suwattanasin, A
Tatiyanupanwong, S
Niwattayakul, K
2014
28. Proteomic Analysis of Kidney in Rats Chronically Exposed to Monosodium Glutamate Sharma, A
Wongkham, C
Prasongwattana, V
Boonnate, P
Thanan, R
Reungjui, S
Cha'on, U
2014
29. ESTIMATED GLOMERULAR FILTRATION RATE AT INITIATION OF DIALYSIS AND OUTCOMES AMONG PATIENTS WITH END-STAGE RENAL DISEASE TREATED WITH TWICE-WEEKLY HEMODIALYSIS Thanachai Panaput
Somneuk Domrongkitchaiporn
Dhavee Sirivongs
Bandit Thinkhamrop
Cholatip Pongskul
Sirirat Anutrakulchai
Suraapong Narenpitak
Pisith Intarawongchot
Sajja Tatiyanuphanwong
Pakorn Tungkasereerak
Chavasak Kanokkantapong
Ammrit Suwattanasin
Laksamon Praderm
Thathsalang Keonounma
Kannika Niwattayakul
2015
30. A multicentre, randomised controlled study of enteric-coated mycophenolate sodium for the treatment of relapsed or resistant proliferative lupus nephritis: an Asian experience Anutrakulchai, S
Panaput, T
Wongchinsri, J
Chaishayanon, S
Satirapoj, B
Traitanon, O
Pima, W
Rukrung, C
Thinkhamrop, B
Avihingsanon, Y
2016
31. Climate Change and the Emergent Epidemic of CKD from Heat Stress in Rural Communities: The Case for Heat Stress Nephropathy Glaser, J
Lemery, J
Rajagopalan, B
Diaz, HF
García-Trabanino, R
Taduri, G
Madero, M
Amarasinghe, M
Abraham, G
Anutrakulchai, S
Jha, V
Stenvinkel, P
Roncal-Jimenez, C
Lanaspa, MA
Correa-Rotter, R
Sheikh-Hamad, D
Burdmann, EA
Andres-Hernando, A
Milagres, T
Weiss, I
Kanbay, M
Wesseling, C
Sánchez-Lozada, LG
Johnson, RJ
2016
32. CLINICAL AND PATHOLOGICAL CHARACTERISTICS OF NONDIABETIC RENAL DISEASE IN TYPE 2 DIABETES PATIENTS Kittrawee Kritmetapak
Sirirat Anutrakulchai
Chatlert Pongchaiyakul
Anucha Puapairoj
2016
33. Erratum to: Mortality and treatment costs of hospitalized chronic kidney disease patients between the three major health insurance schemes in Thailand. Anutrakulchai, S
Mairiang, P
Pongskul, C
Thepsuthammarat, K
Chan-On, C
Thinkhamrop, B
2016
34. Factors associated with mortality and high treatment expense of adult patients hospitalized with chronic kidney disease in Thailand Anutrakulchai, S.
Pongskul, C.
Sirivongs, D.
Thepsuthammarat, K.
Promthet, S.S.
Thinkhamrop, B.
2016
35. Mortality and treatment costs of hospitalized chronic kidney disease patients between the three major health insurance schemes in Thailand Anutrakulchai, S
Mairiang, P
Pongskul, C
Thepsuthammarat, K
Chan-On, C
Thinkhamrop, B
2016
36. Mortality and treatment costs of hospitalized chronic kidney disease patients between the three major health insurance schemes in Thailand (vol 16, 528, 2016) Sirirat Anutrakulchai
Pisaln Mairiang
Cholatip Pongskul
Kaewjai Thepsuthammarat
Chitranon Chan-on
Bandit Thinkhamrop
2016
37. Prevalence of insomnia and related impact. Manjavong, M
Limpawattana, P
Mairiang, P
Anutrakulchai, S
2016
38. Prevalence of insomnia and related impact: An analysis from a university community Manchumad Manjavong
Panita Limpawattana
Pisaln Mairiang
Sirirat Anutrakulchai
2016
39. Relation of peritubular capillary features to class of lupus nephritis. Sirirat Anutrakulchai
Tanin Titipungul
Thanyaluk Pattay
Putachart Mesung
Anucha Puapairoj
Dhavee Sirivongs
Cholatip Pongsakul
Prasit Futrakul
Bandit Thinkhamrop
Richard J. Johnson
2016
40. Utility of body mass index and neck circumference to screen for metabolic syndrome in Thai people Manchumad Manjavong
Panita Limpawattana
Sornwichate Rattanachaiwong
Pisaln Mairiang
Sirirat Reungjui
2017
41. Clinical and pathological characteristics of non-diabetic renal disease in type 2 diabetes patients Kritmetapak, K
Anutrakulchai, S
Pongchaiyakul, C
Puapairoj, A
2018
42. Comparison of disease activity between tacrolimus and mycophenolate mofetil in lupus nephritis: a randomized controlled trial Rattanasiri, S.
Ngamjanyaporn, P.
Anutrakulchai,
2018
43. Poor outcome of peritoneal dialysis during scleroderma renal crisis in scleroderma patients Siriphannon, Y.
Foocharoen, C.
Anutrakulchai, S.
Mahakkanukrauh, A.
Suwannaroj, S.
Nanagara, R.
2018
44. The performance of fat mass index and percent fat mass in predicting metabolic syndrome: A study based on the healthy aging Khon Kaen university campus project Pisprasert, V.
Rattanachaiwong, S.
Hongsprabhas, P.
Limpawattana, P.
Mairiang, P.
Anutrakulchai,
2018
45. URINE TWEAK AS A BIOMARKER FOR EARLY RESPONSE TO TREATMENT IN ACTIVE LUPUS NEPHRITIS: A PROSPECTIVE MULTI-CENTER STUDY Thitima Benjachat Suttichet
Api Chewcharat
Wonngarm Kittanamongkolchai
Chutipha Phromjeen
Sirirat Anutrakulchai
Thanachai Panaput
Atiporn Ingsathit
Nanticha Kamanamool
Vuddhidej Ophascharoensuk
Vasant Sumethakul
Yingyos Avihingsanon
2018
46. Effect of CYP3A5 genotype on hospitalization cost for kidney transplantation Suda Vannaprasaht
Chulaporn Limwattananon
Sirirat Anutrakulchai
Chitranon Chan-on
2019
47. Monosodium Glutamate (MSG) Renders Alkalinizing Properties and Its Urinary Metabolic Markers of MSG Consumption in Rats Phetcharaburanin, J.
Wongkham, C.
Thanan, R.
Silsirivanit, A.
Anutrakulchai,
Chaon, U.
2019
48. Prediction Of Serum Digoxin Concentration Using Estimated Glomerular Filtration Rate In Thai Population. Jaisue, S.
Anutrakulchai,
Kanjanavanit, R.
2019
49. The effects of individualized nutritional management to slow the progression of stage 3 to 4 chronic kidney disease in primary care units of northeast Thailand Anutrakulchai, 2019
50. The impact of self-management and case management on progression of chronic kidney disease in urban communities of Khon Kaen Anutrakulchai, 2019
51. Therapeutic concentration achievement and allograft survival comparing usage of conventional tacrolimus doses and CYP3A5 genotype-guided doses in renal transplantation patients. Sirirat Anutrakulchai
Cholatip Pongskul
Kittrawee Kritmetapak
Chulaporn Limwattananon
Suda Vannaprasaht
2019
52. Urine TWEAK level as a biomarker for early response to treatment in active lupus nephritis: a prospective multicentre study. Thitima Benjachat Suttichet
Wonngarm Kittanamongkolchai
Chutipha Phromjeen
Sirirat Anutrakulchai
Thanachai Panaput
Atiporn Ingsathit
Nanticha Kamanamool
Vuddhidej Ophascharoensuk
Vasant Sumethaku
Yingyos Avihingsanon
2019
53. A combination of monosodium glutamate and high-fat and high-fructose diets increases the risk of kidney injury, gut dysbiosis and host-microbial co-metabolism. Haonon, O.
Onsurathum, S.
Jusakul, A.
Intuyod, K.
Sangka, A.
Anutrakulchai, S.
Cha'on, U.
Pinlaor, S.
Pinlaor, P.
2020
54. Cognitive impairment, quality of life and healthcare utilization in patients with chronic kidney disease stages 3 to 5 Waleekhachonloet, O.a.
Limwattananon, C.
Anutrakulchai, S.
2020
55. Improved agar plate culture conditions for diagnosis of Strongyloides stercoralis Wannee Kaewrat
Chatchawan Sengthong
Manachai Yingklang
Kitti Intuyod
Ornuma Haonon
Sudarat Onsurathum
Rungtiwa Dangtakot
Phitsamai Saisud
Arunnee Sangka
Sirirat Anutrakulchai
Somchai Pinlaor
Ubon Cha'on
Porntip Pinlaor
2020
Count 42 37 41 0

Title Authors Year Publication name Cited count
< 2015 2016 2017 2018 2019 2020 รวม
1. Correlation between Na, K-ATPase activity and potassium and magnesium contents in skeletal muscle of renal stone patients Prasongwatana, V.
Tavichakorntrakool, R.
Sriboonlue, P.
Wongkham, C.
Bovornpadungkitti, S.
Premgamone, A.
Reungjuiy, S.
2001 Southeast Asian Journal of Tropical Medicine and Public Health
3 (32), pp. 648-653
2. Magnesium status of patients with renal stones and its effect on urinary citrate excretion Reungjui, S.
Prasongwatana, V.
Premgamone, A.
Tosukhowong, P.
Jirakulsomchok, S.
Sriboonlue, P.
2002 BJU International
7 (90), pp. 635-639
3. Urinary citrate excretion in patients with renal stone: Roles of leucocyte ATP citrate lyase activity and potassium salts therapy Tosukhowong, P.
Prasongwatana, V.
Tungsanga, K.
Reungjui, S.
Sriboonlue, P.
2002 Clinica Chimica Acta
1-2 (325), pp. 71-78
4. Azathioprine-induced fatal myelosuppression in a renal-transplant recipient who carried heterozygous TPMT*1/*3C [4] Tassaneeyakul, W.
Srimarthpirom, S.
Reungjui, S.
Chansung, G.
Romphruk, A.V.
Tassaneeyakul, W.
2003 Transplantation
1 (76), pp. 265-266
5. Graft survival analysis in kidney transplantation: A 12-year experience in a Thai medical center Sirivongs, D.
Liawnoraset, W.
Pongskul, C.
Reungjui, S.
2004 Transplantation Proceedings
7 (36), pp. 2034-2037
6. The effects of potassium and magnesium supplementations on urinary risk factors of renal stone patients Jaipakdee, S.
Prasongwatana, V.
Premgamone, A.
Reungjui, S.
Tosukhowong, P.
Tungsanga, K.
Suwantrai, S.
Noppawinyoowong, C.
Maskasame, S.
Sriboonlue, P.
2004 Journal of the Medical Association of Thailand
3 (87), pp. 255-263
7. Ceftazidime overdose-related nonconvulsive status epilepticus after intraperitoneal instillation Vannaprasaht, S.
Tawalee, A.
Mayurasakorn, N.
Yodwut, C.
Bansong, R.
Reungjui, S.
Tiamkao, S.
2006 Clinical Toxicology
4 (44), pp. 383-386
8. Uric acid, the metabolic syndrome, and renal disease Cirillo, P.
Sato, W.
Reungjui, S.
Heinig, M.E.
Nakagawa, T.
Johnson, R.J.
2006 Journal of the American Society of Nephrology
SUPPL. 3 (17), pp. S165-S168
9. Effect of elevated serum uric acid on cisplatin-induced acute renal failure Reungjui, S.
Tabah-Fisch, I.
Johnson, R.J.
2007 American Journal of Physiology - Renal Physiology
1 (292), pp. F116-F122
10. Effect of reduced renal mass on renal ammonia transporter family, Rh C glycoprotein and Rh B glycoprotein, expression Kim, H.
Baylis, C.E.
Han, K.
Reungjui, S.
Weiner, I.D.
2007 American Journal of Physiology - Renal Physiology
4 (293), pp. F1238-F1247
11. Effects of ischemia-reperfusion injury on renal ammonia metabolism and the collecting duct Han, K.
Kim, H.
Reungjui, S.
Lee, S.
Kim, J.
Weiner, I.D.
2007 American Journal of Physiology - Renal Physiology
4 (293), pp. F1342-F1354
12. Fructose, but not dextrose, accelerates the progression of chronic kidney disease Cirillo, P.
Reungjui, S.
Johnson, R.J.
Nakagawa, T.
2007 American Journal of Physiology - Renal Physiology
4 (293), pp. F1256-F1261
13. Lead, at low levels, accelerates arteriolopathy and tubulointerstitial injury in chronic kidney disease Reungjui, S.
Nakagawa, T.
Johnson, R.J.
2007 American Journal of Physiology - Renal Physiology
4 (293), pp. F1391-F1396
14. Thiazide diuretics exacerbate fructose-induced metabolic syndrome Reungjui, S.
Srinivas, T.R.
Sirivongs, D.
Johnson, R.J.
Nakagawa, T.
2007 Journal of the American Society of Nephrology
10 (18), pp. 2724-2731
15. Thiazide-induced subtle renal injury not observed in states of equivalent hypokalemia Reungjui, S.
Hu, H.
Nakagawa, T.
Srinivas, T.R.
Byer, K.J.
Sitprija, V.
Johnson, R.J.
2007 Kidney International
12 (72), pp. 1483-1492
16. Do thiazides worsen metabolic syndrome and renal disease? The pivotal roles for hyperuricemia and hypokalemia Reungjui, S.
Pratipanawatr, T.
Johnson, R.J.
Nakagawa, T.
2008 Current Opinion in Nephrology and Hypertension
5 (17), pp. 470-476
17. Hypokalemic nephropathy is associated with impaired angiogenesis Reungjui, S.
Sato, W.
Tungsanga, K.
Nakagawa, T.
Johnson, R.J.
2008 Journal of the American Society of Nephrology
1 (19), pp. 125-134
18. Response to 'Thiazide diuretics: Rat versus man' Reungjui, S.
Johnson, R.J.
2008 Kidney International
6 (74), pp. 831
19. Combination of captopril and allopurinol retards fructose-induced metabolic syndrome Reungjui, S.
Nakagawa, T.
Johnson, R.J.
2009 American Journal of Nephrology
5 (30), pp. 399-404
20. Comparison of free fructose and glucose to sucrose in the ability to cause fatty liver Reungjui, S.
Le, M.
Nakagawa, T.
Lan, H.Y.
Yu, X.
Johnson, R.J.
2010 European Journal of Nutrition
1 (49), pp. 1-9
21. Disease patterns among Thai adult population: an analysis of data from the hospitalization National Health Insurance System 2010. Anunnatsiri, S.
Reungjui, S.
Thavornpitak, Y.
Mairiang, P.
2012 Journal of the Medical Association of Thailand = Chotmaihet thangphaet
(95 Suppl 7), pp. S74-80
22. Health insurance system and healthcare provision: nationwide hospital admission data 2010. Reungjui, S.
Anunnatsiri, S.
Limwattananon, C.
Thavornpitak, Y.
Mairiang, P.
2012 Journal of the Medical Association of Thailand = Chotmaihet thangphaet
(95 Suppl 7), pp. S240-253
23. Monosodium Glutamate (MSG) Consumption Is Associated with Urolithiasis and Urinary Tract Obstruction in Rats Sharma, A.
Prasongwattana, V.
Cha'on, U.
Hipkaeo, W.
Boonnate, P.
Pethlert, S.
Titipungul, T.
Intarawichian, P.
Waraasawapati, S.
Puapiroj, A.
Sitprija, V.
Reungjui, S.
2013 PLoS ONE
9 (8), pp.
24. Personalized tacrolimus doses determined by CYP3A5 genotype for induction and maintenance phases of kidney transplantation Vannaprasaht, S.
Reungjui, S.
Supanya, D.
Sirivongs, D.
Pongskul, C.
Avihingsanon, Y.
Tassaneeyakul, W.
2013 Clinical Therapeutics
11 (35), pp. 1762-1769
25. Dialysis dose and risk factors for death among ESRD patients treated with twice-weekly hemodialysis: A prospective cohort study Panaput, T.
Thinkhamrop, B.
Sirivongs, D.
Praderm, L.
Anukulanantachai, J.
Pongskul, C.
Anutrakulchai, S.
Keobounma, T.
Narenpitak, S.
Intarawongchot, P.
Suwattanasin, A.
Tatiyanupanwong, S.
2014 Blood Purification
3-4 (38), pp. 253-262
26. Factors associated with mortality and high treatment expense of adult patients hospitalized with chronic kidney disease in Thailand Anutrakulchai, S.
Pongskul, C.
Sirivongs, D.
Thepsuthammarat, K.
Promthet, S.S.
Thinkhamrop, B.
2016 Asian Biomedicine
1 (10), pp. 15-24
27. Mortality and treatment costs of hospitalized chronic kidney disease patients between the three major health insurance schemes in Thailand Anutrakulchai, S.
Mairiang, P.
Pongskul, C.
Thepsuthammarat, K.
Chan-On, C.
Thinkhamrop, B.
2016 BMC Health Services Research
1 (16), pp. 1-11
28. Utility of body mass index and neck circumference to screen for metabolic syndrome in Thai people Limpawattana, P.
Mairiang, P.
Reungjui, S.
2017 Asian Biomedicine
1 (11), pp. 55-63
29. Clinical and pathological characteristics of non-diabetic renal disease in type 2 diabetes patients Kritmetapak , K
Anutrakulchai,
Pongchaiyakul, C.
2018 Clinical Kidney Journal
3 (11), pp. 342-347
30. Comparison of disease activity between tacrolimus and mycophenolate mofetil in lupus nephritis: a randomized controlled trial Rattanasiri, S.
Ngamjanyaporn, P.
Anutrakulchai,
2018 Lupus
4 (27), pp. 647-656
31. Poor outcome of peritoneal dialysis during scleroderma renal crisis in scleroderma patients Siriphannon, Y.
Foocharoen, C.
Anutrakulchai, S.
Mahakkanukrauh, A.
Suwannaroj, S.
Nanagara, R.
2018 Journal of the Medical Association of Thailand
7 (101), pp. S235-S243
32. The performance of fat mass index and percent fat mass in predicting metabolic syndrome: A study based on the healthy aging Khon Kaen university campus project Pisprasert, V.
Rattanachaiwong, S.
Hongsprabhas, P.
Limpawattana, P.
Mairiang, P.
Anutrakulchai,
2018 Journal of the Medical Association of Thailand
7 (101), pp. S15-S22
33. Effect of CYP3A5 genotype on hospitalization cost for kidney transplantation Vannaprasaht, S.
Limwattananon, C.
Anutrakulchai,
Chan-On, C.
2019 International Journal of Clinical Pharmacy
1 (41), pp. 88-95
34. Monosodium glutamate (MSG) renders alkalinizing properties and its urinary metabolic markers of MSG consumption in rats Phetcharaburanin, J.
Wongkham, C.
Thanan, R.
Silsirivanit, A.
Anutrakulchai,
Chaon, U.
2019 Biomolecules
10 (9), pp.
35. Prediction of serum digoxin concentration using estimated glomerular filtration rate in Thai population Jaisue, S.
Anutrakulchai,
Kanjanavanit, R.
2019 International Journal of General Medicine
(12), pp. 455-463
36. The effects of individualized nutritional management to slow the progression of stage 3 to 4 chronic kidney disease in primary care units of northeast Thailand Anutrakulchai, 2019 Journal of the Medical Association of Thailand
8 (102), pp. 38-44
37. The impact of self-management and case management on progression of chronic kidney disease in urban communities of Khon Kaen Anutrakulchai, 2019 Journal of the Medical Association of Thailand
8 (102), pp. 30-37
38. Therapeutic concentration achievement and allograft survival comparing usage of conventional tacrolimus doses and CYP3A5 genotype-guided doses in renal transplantation patients Anutrakulchai,
Pongskul, C.
Kritmetapak , K
Limwattananon, C.
Vannaprasaht, S.
2019 British Journal of Clinical Pharmacology
9 (85), pp. 1964-1973
39. Urine TWEAK level as a biomarker for early response to treatment in active lupus nephritis: A prospective multicentre study Kittanamongkolchai, W.
Anutrakulchai,
Panaput, T.
2019 Lupus Science and Medicine
1 (6), pp.
40. A combination of monosodium glutamate and high-fat and high-fructose diets increases the risk of kidney injury, gut dysbiosis and host-microbial co-metabolism Haonon, O.
Onsurathum, S.
Jusakul, A.
Intuyod, K.
Sangka, A.
Anutrakulchai, S.
Cha'on, U.
Pinlaor, S.
Pinlaor, P.
2020 PLoS ONE
4 (15), pp.
41. Cognitive impairment, quality of life and healthcare utilization in patients with chronic kidney disease stages 3 to 5 Waleekhachonloet, O.a.
Limwattananon, C.
Anutrakulchai, S.
2020 Nephrology
(), pp.
42. Improved agar plate culture conditions for diagnosis of Strongyloides stercoralis Sengthong, C.
Intuyod, K.
Haonon, O.
Onsurathum, S.
Saisud, P.
Sangka, A.
Anutrakulchai, S.
Pinlaor, S.
Cha'on, U.
Pinlaor, P.
2020 Acta Tropica
(203), pp.

Title Authors Year Journal title
1. The effect of prostaglandin E1 analog misoprostol on chronic cyclosporin nephrotoxicity. John, EG
Fornell, LC
Radhakrishnan, J
Anutrakulchai, S
Jonasson, O
1993 Journal of pediatric surgery
11 (28), pp. 1429-31; discussion 1432
2. Magnesium status of patients with renal stones and its effect on urinary citrate excretion. Reungjui, S
Prasongwatana, V
Premgamone, A
Tosukhowong, P
Jirakulsomchok, S
Sriboonlue, P
2002 BJU international
7 (90), pp. 635-9
3. Urinary citrate excretion in patients with renal stone: roles of leucocyte ATP citrate lyase activity and potassium salts therapy. Tosukhowong, P
Borvonpadungkitti, S
Prasongwatana, V
Tungsanga, K
Jutuporn, S
Dissayabutr, T
Reungjui, S
Sriboonlue, P
2002 Clinica chimica acta; international journal of clinical chemistry
1 (325), pp. 71-8
4. Azathioprine-induced fatal myelosuppression in a renal-transplant recipient who carried heterozygous TPMT*1/*3C. Tassaneeyakul, W
Srimarthpirom, S
Reungjui, S
Chansung, K
Romphruk, A
Tassaneeyakul, W
2003 Transplantation
1 (76), pp. 265-6
5. The effects of potassium and magnesium supplementations on urinary risk factors of renal stone patients. Jaipakdee, S
Prasongwatana, V
Premgamone, A
Reungjui, S
Tosukhowong, P
Tungsanga, K
Suwantrai, S
Noppawinyoowong, C
Maskasame, S
Sriboonlue, P
2004 Journal of the Medical Association of Thailand = Chotmaihet thangphaet
3 (87), pp. 255-63
6. Graft survival analysis in kidney transplantation: a 12-year experience in a Thai medical center. Sirivongs, D
Liawnoraset, W
Pongskul, C
Reungjui, S
2004 Transplantation proceedings
7 (36), pp. 2034-7
7. Uric acid, the metabolic syndrome, and renal disease. Cirillo, P
Sato, W
Reungjui, S
Heinig, M
Gersch, M
Sautin, Y
Nakagawa, T
Johnson, RJ
2006 Journal of the American Society of Nephrology : JASN
12 (17), pp. S165-8
8. Ceftazidime overdose-related nonconvulsive status epilepticus after intraperitoneal instillation. Vannaprasaht, S
Tawalee, A
Mayurasakorn, N
Yodwut, C
Bansong, R
Reungjui, S
Tiamkao, S
2006 Clinical toxicology (Philadelphia, Pa.)
4 (44), pp. 383-6
9. Thiazide-induced subtle renal injury not observed in states of equivalent hypokalemia. Reungjui, S
Hu, H
Mu, W
Roncal, CA
Croker, BP
Patel, JM
Nakagawa, T
Srinivas, T
Byer, K
Simoni, J
Wesson, D
Sitprija, V
Johnson, RJ
2007 Kidney international
12 (72), pp. 1483-92
10. Effect of reduced renal mass on renal ammonia transporter family, Rh C glycoprotein and Rh B glycoprotein, expression. Kim, HY
Baylis, C
Verlander, JW
Han, KH
Reungjui, S
Handlogten, ME
Weiner, ID
2007 American journal of physiology. Renal physiology
4 (293), pp. F1238-47
11. Fructose, but not dextrose, accelerates the progression of chronic kidney disease. Gersch, MS
Mu, W
Cirillo, P
Reungjui, S
Zhang, L
Roncal, C
Sautin, YY
Johnson, RJ
Nakagawa, T
2007 American journal of physiology. Renal physiology
4 (293), pp. F1256-61
12. Effect of elevated serum uric acid on cisplatin-induced acute renal failure. Roncal, CA
Mu, W
Croker, B
Reungjui, S
Ouyang, X
Tabah-Fisch, I
Johnson, RJ
Ejaz, AA
2007 American journal of physiology. Renal physiology
1 (292), pp. F116-22
13. Lead, at low levels, accelerates arteriolopathy and tubulointerstitial injury in chronic kidney disease. Roncal, C
Mu, W
Reungjui, S
Kim, KM
Henderson, GN
Ouyang, X
Nakagawa, T
Johnson, RJ
2007 American journal of physiology. Renal physiology
4 (293), pp. F1391-6
14. Thiazide diuretics exacerbate fructose-induced metabolic syndrome. Reungjui, S
Roncal, CA
Mu, W
Srinivas, TR
Sirivongs, D
Johnson, RJ
Nakagawa, T
2007 Journal of the American Society of Nephrology : JASN
10 (18), pp. 2724-31
15. Effects of ischemia-reperfusion injury on renal ammonia metabolism and the collecting duct. Han, KH
Kim, HY
Croker, BP
Reungjui, S
Lee, SY
Kim, J
Handlogten, ME
Adin, CA
Weiner, ID
2007 American journal of physiology. Renal physiology
4 (293), pp. F1342-54
16. Hypokalemic nephropathy is associated with impaired angiogenesis. Reungjui, S
Roncal, CA
Sato, W
Glushakova, OY
Croker, BP
Suga, S
Ouyang, X
Tungsanga, K
Nakagawa, T
Johnson, RJ
Mu, W
2008 Journal of the American Society of Nephrology : JASN
1 (19), pp. 125-34
17. Do thiazides worsen metabolic syndrome and renal disease? The pivotal roles for hyperuricemia and hypokalemia. Reungjui, S
Pratipanawatr, T
Johnson, RJ
Nakagawa, T
2008 Current opinion in nephrology and hypertension
5 (17), pp. 470-6
18. Combination of captopril and allopurinol retards fructose-induced metabolic syndrome. Roncal, CA
Reungjui, S
Sánchez-Lozada, LG
Mu, W
Sautin, YY
Nakagawa, T
Johnson, RJ
2009 American journal of nephrology
5 (30), pp. 399-404
19. Comparison of free fructose and glucose to sucrose in the ability to cause fatty liver. Sánchez-Lozada, LG
Mu, W
Roncal, C
Sautin, YY
Abdelmalek, M
Reungjui, S
Le, M
Nakagawa, T
Lan, HY
Yu, X
Johnson, RJ
2010 European journal of nutrition
1 (49), pp. 1-9
20. Disease patterns among Thai adult population: an analysis of data from the hospitalization National Health Insurance System 2010. Anunnatsiri, S
Reungjui, S
Thavornpitak, Y
Pukdeesamai, P
Mairiang, P
2012 Journal of the Medical Association of Thailand = Chotmaihet thangphaet
(95), pp. S74-80
21. Health insurance system and healthcare provision: nationwide hospital admission data 2010. Reungjui, S
Anunnatsiri, S
Limwattananon, C
Thavornpitak, Y
Pukdeesamai, P
Mairiang, P
2012 Journal of the Medical Association of Thailand = Chotmaihet thangphaet
(95), pp. S240-53
22. Personalized tacrolimus doses determined by CYP3A5 genotype for induction and maintenance phases of kidney transplantation. Vannaprasaht, S
Reungjui, S
Supanya, D
Sirivongs, D
Pongskul, C
Avihingsanon, Y
Tassaneeyakul, W
2013 Clinical therapeutics
11 (35), pp. 1762-9
23. Monosodium glutamate (MSG) consumption is associated with urolithiasis and urinary tract obstruction in rats. Sharma, A
Prasongwattana, V
Cha'on, U
Selmi, C
Hipkaeo, W
Boonnate, P
Pethlert, S
Titipungul, T
Intarawichian, P
Waraasawapati, S
Puapiroj, A
Sitprija, V
Reungjui, S
2013 PloS one
9 (8), pp. e75546
24. Proteomic analysis of kidney in rats chronically exposed to monosodium glutamate. Sharma, A
Wongkham, C
Prasongwattana, V
Boonnate, P
Thanan, R
Reungjui, S
Cha'on, U
2014 PloS one
12 (9), pp. e116233
25. Dialysis dose and risk factors for death among ESRD patients treated with twice-weekly hemodialysis: a prospective cohort study. Panaput, T
Thinkhamrop, B
Domrongkitchaiporn, S
Sirivongs, D
Praderm, L
Anukulanantachai, J
Kanokkantapong, C
Tungkasereerak, P
Pongskul, C
Anutrakulchai, S
Keobounma, T
Narenpitak, S
Intarawongchot, P
Suwattanasin, A
Tatiyanupanwong, S
Niwattayakul, K
2014 Blood purification
3 (38), pp. 253-62
26. Mortality and treatment costs of hospitalized chronic kidney disease patients between the three major health insurance schemes in Thailand. Anutrakulchai, S
Mairiang, P
Pongskul, C
Thepsuthammarat, K
Chan-On, C
Thinkhamrop, B
2016 BMC health services research
1 (16), pp. 528
27. A multicentre, randomised controlled study of enteric-coated mycophenolate sodium for the treatment of relapsed or resistant proliferative lupus nephritis: an Asian experience. Anutrakulchai, S
Panaput, T
Wongchinsri, J
Chaishayanon, S
Satirapoj, B
Traitanon, O
Pima, W
Rukrung, C
Thinkhamrop, B
Avihingsanon, Y
2016 Lupus science & medicine
1 (3), pp. e000120
28. Climate Change and the Emergent Epidemic of CKD from Heat Stress in Rural Communities: The Case for Heat Stress Nephropathy. Glaser, J
Lemery, J
Rajagopalan, B
Diaz, HF
García-Trabanino, R
Taduri, G
Madero, M
Amarasinghe, M
Abraham, G
Anutrakulchai, S
Jha, V
Stenvinkel, P
Roncal-Jimenez, C
Lanaspa, MA
Correa-Rotter, R
Sheikh-Hamad, D
Burdmann, EA
Andres-Hernando, A
Milagres, T
Weiss, I
Kanbay, M
Wesseling, C
Sánchez-Lozada, LG
Johnson, RJ
2016 Clinical journal of the American Society of Nephrology : CJASN
8 (11), pp. 1472-83
29. Prevalence of insomnia and related impact. Manjavong, M
Limpawattana, P
Mairiang, P
Anutrakulchai, S
2016 International journal of psychiatry in medicine
6 (51), pp. 544-553
30. Erratum to: Mortality and treatment costs of hospitalized chronic kidney disease patients between the three major health insurance schemes in Thailand. Anutrakulchai, S
Mairiang, P
Pongskul, C
Thepsuthammarat, K
Chan-On, C
Thinkhamrop, B
2016 BMC health services research
1 (16), pp. 614
31. Relation of peritubular capillary features to class of lupus nephritis. Anutrakulchai, S
Titipungul, T
Pattay, T
Mesung, P
Puapairoj, A
Sirivongs, D
Pongsakul, C
Futrakul, P
Thinkhamrop, B
Johnson, RJ
2016 BMC nephrology
1 (17), pp. 169
32. Clinical and pathological characteristics of non-diabetic renal disease in type 2 diabetes patients. Kritmetapak, K
Anutrakulchai, S
Pongchaiyakul, C
Puapairoj, A
2018 Clinical kidney journal
3 (11), pp. 342-347
33. Therapeutic concentration achievement and allograft survival comparing usage of conventional tacrolimus doses and CYP3A5 genotype-guided doses in renal transplantation patients. Anutrakulchai, S
Pongskul, C
Kritmetapak, K
Limwattananon, C
Vannaprasaht, S
2019 British journal of clinical pharmacology
9 (85), pp. 1964-1973
34. Urine TWEAK level as a biomarker for early response to treatment in active lupus nephritis: a prospective multicentre study. Suttichet, TB
Kittanamongkolchai, W
Phromjeen, C
Anutrakulchai, S
Panaput, T
Ingsathit, A
Kamanamool, N
Ophascharoensuk, V
Sumethakul, V
Avihingsanon, Y
2019 Lupus science & medicine
1 (6), pp. e000298
35. Effect of CYP3A5 genotype on hospitalization cost for kidney transplantation. Vannaprasaht, S
Limwattananon, C
Anutrakulchai, S
Chan-On, C
2019 International journal of clinical pharmacy
1 (41), pp. 88-95
36. Prediction Of Serum Digoxin Concentration Using Estimated Glomerular Filtration Rate In Thai Population. Sae-Lim, O
Doungngern, T
Jaisue, S
Cheewatanakornkul, S
Arunmanakul, P
Anutrakulchai, S
Kanjanavanit, R
Wongpoowarak, W
2019 International journal of general medicine
(12), pp. 455-463
37. A combination of monosodium glutamate and high-fat and high-fructose diets increases the risk of kidney injury, gut dysbiosis and host-microbial co-metabolism. Pongking, T
Haonon, O
Dangtakot, R
Onsurathum, S
Jusakul, A
Intuyod, K
Sangka, A
Anutrakulchai, S
Cha'on, U
Pinlaor, S
Pinlaor, P
2020 PloS one
4 (15), pp. e0231237

Title Authors Year Journal title Cited count
< 2015 2016 2017 2018 2019 2020 รวม
1. Magnesium status of patients with renal stones and its effect on urinary citrate excretion S Reungjui
V Prasongwatana
A Premgamone
P Tosukhowong
S Jirakulsomchok
P Sriboonlue
2002 BJU INTERNATIONAL
7.0 (90.0), pp. 635.0-639.0
27 0 0 0 0 0 27
2. Urinary citrate excretion in patients with renal stone: roles of leucocyte ATP citrate lyase activity and potassium salts therapy P Tosukhowong
S Borvonpadungkitti
V Prasongwatana
K Tungsanga
S Jutuporn
T Dissayabutr
S Reungjui
P Sriboonlue
2002 CLINICA CHIMICA ACTA
1-2 (325.0), pp. 71.0-78.0
29 0 0 0 0 0 29
3. Azathioprine-induced fatal myelosuppression in a renal-transplant recipient who carried heterozygous TPMT*1/*3C S Srimarthpirom
S Reungjui
K Chansung
A Romphurk
W Tassaneeyakul
2003 TRANSPLANTATION
1.0 (76.0), pp. 265.0-266.0
38 0 0 0 0 0 38
4. Graft survival analysis in kidney transplantation: A 12-year experience in a Thai Medical Center D Sirivongs
W Liawnoraset
C Pongskul
S Reungjui
2004 TRANSPLANTATION PROCEEDINGS
7.0 (36.0), pp. 2034.0-2037.0
6 0 0 0 0 0 6
5. Ceftazidime overdose-related nonconvulsive status epilepticus after intraperitoneal instillation S Vannaprasaht
A Tawalee
N Mayurasakorn
C Yodwut
R Bansong
S Reungjui
S Tiamkao
2006 CLINICAL TOXICOLOGY
4.0 (44.0), pp. 383.0-386.0
20 0 0 0 0 0 20
6. Uric acid, the metabolic syndrome, and renal disease Pietro Girillo
Waichi Sato
Sirirat Reungjui
Marcelo Heinig
Michael Gersch
Yuri Sautin
Takahiko Nakagawa
Richard J. Johnson
2006 JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
(17.0), pp. S165-S168
87 0 0 0 0 0 87
7. Effect of elevated serum uric acid on cisplatin-induced acute renal failure Carlos A. Roncal
Wei Mu
Byron Croker
Sirirat Reungjui
Xiaosen Ouyang
Isabelle Tabah-Fisch
Richard J. Johnson
A. Ahsan Ejaz
2007 AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY
1.0 (292.0), pp. F116-F122
111 0 0 0 0 0 111
8. Effect of reduced renal mass on renal ammonia transporter family, RhC glycoprotein and RhB glycoprotein, expression Hye-Young Kim
Chris Baylis
Jill W. Verlander
Ki-Hwan Han
Sirirat Reungjui
Mary E. Handlogten
I. David Weiner
2007 AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY
4.0 (293.0), pp. F1238-F1247
72 0 0 0 0 0 72
9. Effects of ischemia-reperfusion injury on renal ammonia metabolism and the collecting duct Ki-Hwan Han
Hye-Young Kim
Byron P. Croker
Sirirat Reungjui
Su-Youn Lee
Jin Kim
Mary E. Handlogten
Christopher A. Adin
I. David Weiner
2007 AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY
4.0 (293.0), pp. F1342-F1354
34 0 0 0 0 0 34
10. Fructose, but not dextrose, accelerates the progression of chronic kidney disease Michael S. Gersch
Wei Mu
Pietro Cirillo
Sirirat Reungjui
Li Zhang
Carlos Roncal
Yuri Y. Sautin
Richard J. Johnson
Takahiko Nakagawa
2007 AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY
4.0 (293.0), pp. F1256-F1261
164 0 0 0 0 0 164
11. Lead, at low levels, accelerates arteriolopathy and tubulointerstitial injury in chronic kidney disease Carlos Roncal
Wei Mu
Sirirat Reungjui
Kyung Mee Kim
George N. Henderson
Xiaosen Ouyang
Takahiko Nakagawa
Richard J. Johnson
2007 AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY
4.0 (293.0), pp. F1391-F1396
29 0 0 0 0 0 29
12. Thiazide diuretics exacerbate fructose-induced metabolic syndrome Sirirat Reungjui
Carlos A. Roncal
Wei Mu
Titte R. Srinivas
Dhavee Sirivongs
Richard J. Johnson
Takahiko Nakagawa
2007 JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
10.0 (18.0), pp. 2724.0-2731.0
134 0 0 0 0 0 134
13. Thiazide-induced subtle renal injury not observed in states of equivalent hypokalemia S. Reungjui
H. Hu
W. Mu
C. A. Roncal
B. P. Croker
J. M. Patel
T. Nakagawa
T. Srinivas
K. Byer
J. Simoni
D. Wesson
V. Sitprija
R. J. Johnson
2007 KIDNEY INTERNATIONAL
12.0 (72.0), pp. 1483.0-1492.0
57 0 0 0 0 0 57
14. Do thiazides worsen metabolic syndrome and renal disease? The pivotal roles for hyperuricemia and hypokalemia Sirirat Reungjui
Thongchai Pratipanawatr
Richard J. Johnson
Takahiko Nakagawa
2008 CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
5.0 (17.0), pp. 470.0-476.0
55 0 0 0 0 0 55
15. Hypokalemic nephropathy is associated with impaired angiogenesis Sirirat Reungjui
Carlos A. Roncal
Waichi Sato
Olena Y. Glushakova
Byron P. Croker
Shin-ichi Suga
Xiaosen Ouyang
Kriang Tungsanga
Takahiko Nakagawa
Richard J. Johnson
Wei Mu
2008 JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
1.0 (19.0), pp. 125.0-134.0
50 0 0 0 0 0 50
16. Response to 'Thiazide diuretics: rat versus man' Sirirat Reungjui
Richard J. Johnson
2008 KIDNEY INTERNATIONAL
6.0 (74.0), pp. 831.0-831.0
0 0 0 0 0 0 0
17. Combination of Captopril and Allopurinol Retards Fructose-Induced Metabolic Syndrome Carlos A. Roncal
Sirirat Reungjui
Laura Gabriela Sanchez-Lozada
Wei Mu
Yuri Y. Sautin
Takahiko Nakagawa
Richard J. Johnson
2009 AMERICAN JOURNAL OF NEPHROLOGY
5.0 (30.0), pp. 399.0-404.0
52 0 0 0 0 0 52
18. Comparison of free fructose and glucose to sucrose in the ability to cause fatty liver Laura G. Sanchez-Lozada
Wei Mu
Carlos Roncal
Yuri Y. Sautin
Manal Abdelmalek
Sirirat Reungjui
MyPhuong Le
Takahiko Nakagawa
Hui Y. Lan
Xuequing Yu
Richard J. Johnson
2010 EUROPEAN JOURNAL OF NUTRITION
1.0 (49.0), pp. 1.0-9.0
83 0 0 0 0 0 83
19. Monosodium Glutamate (MSG) Consumption Is Associated with Urolithiasis and Urinary Tract Obstruction in Rats Amod Sharma
Vitoon Prasongwattana
Ubon Cha'on
Carlo Selmi
Wiphawi Hipkaeo
Piyanard Boonnate
Supattra Pethlert
Tanin Titipungul
Piyapharom Intarawichian
Sakda Waraasawapati
Anucha Puapiroj
Visith Sitprija
Sirirat Reungjui
2013 PLOS ONE
9.0 (8.0), pp.
11 0 0 0 0 0 11
20. Personalized Tacrolimus Doses Determined by CYP3A5 Genotype for Induction and Maintenance Phases of Kidney Transplantation Suda Vannaprasaht
Sirirat Reungjui
Darika Supanya
Dhavee Sirivongs
Cholatip Pongskul
Yingyos Avihingsanon
Wichittra Tassaneeyakul
2013 CLINICAL THERAPEUTICS
11.0 (35.0), pp. 1762.0-1769.0
31 0 0 0 0 0 31
21. Dialysis Dose and Risk Factors for Death Among ESRD Patients Treated with Twice-Weekly Hemodialysis: A Prospective Cohort Study Thanachai Panaput
Bandit Thinkhamrop
Somnuek Domrongkitchaiporn
Dhavee Sirivongs
Laksamon Praderm
Jirasak Anukulanantachai
Chavasak Kanokkantapong
Pakorn Tungkasereerak
Cholatip Pongskul
Sirirat Anutrakulchai
Thathsalang Keobounma
Surapong Narenpitak
Pisith Intarawongchot
Ammrit Suwattanasin
Sajja Tatiyanupanwong
Kannika Niwattayakul
2014 BLOOD PURIFICATION
3-4 (38.0), pp. 253.0-262.0
21 0 0 0 0 0 21
22. Proteomic Analysis of Kidney in Rats Chronically Exposed to Monosodium Glutamate Amod Sharma
Chaisiri Wongkham
Vitoon Prasongwattana
Piyanard Boonnate
Raynoo Thanan
Sirirat Reungjui
Ubon Cha'on
2014 PLOS ONE
12.0 (9.0), pp.
20 0 0 0 0 0 20
23. ESTIMATED GLOMERULAR FILTRATION RATE AT INITIATION OF DIALYSIS AND OUTCOMES AMONG PATIENTS WITH END-STAGE RENAL DISEASE TREATED WITH TWICE-WEEKLY HEMODIALYSIS Thanachai Panaput
Somneuk Domrongkitchaiporn
Dhavee Sirivongs
Bandit Thinkhamrop
Cholatip Pongskul
Sirirat Anutrakulchai
Suraapong Narenpitak
Pisith Intarawongchot
Sajja Tatiyanuphanwong
Pakorn Tungkasereerak
Chavasak Kanokkantapong
Ammrit Suwattanasin
Laksamon Praderm
Thathsalang Keonounma
Kannika Niwattayakul
2015 NEPHROLOGY DIALYSIS TRANSPLANTATION
(30.0), pp.
0 0 0 0 0 0 0
24. A multicentre, randomised controlled study of enteric-coated mycophenolate sodium for the treatment of relapsed or resistant proliferative lupus nephritis: an Asian experience Sirirat Anutrakulchai
Thanachai Panaput
Jeerapat Wongchinsri
Somchai Chaishayanon
Bancha Satirapoj
Opas Traitanon
Warabhorn Pima
Chutima Rukrung
Bandit Thinkhamrop
Yingyos Avihingsanon
2016 LUPUS SCIENCE & MEDICINE
1.0 (3.0), pp.
7 0 0 0 0 0 7
25. Climate Change and the Emergent Epidemic of CKD from Heat Stress in Rural Communities: The Case for Heat Stress Nephropathy Jason Glaser
Jay Lemery
Balaji Rajagopalan
Henry F. Diaz
Ramon Garcia-Trabanino
Gangadhar Taduri
Magdalena Madero
Mala Amarasinghe
Georgi Abraham
Sirirat Anutrakulchai
Vivekanand Jha
Peter Stenvinkel
Carlos Roncal-Jimenez
Miguel A. Lanaspa
Ricardo Correa-Rotter
David Sheikh-Hamad
Emmanuel A. Burdmann
Ana Andres-Hernando
Tamara Milagres
Ilana Weiss
Mehmet Kanbay
Catharina Wesseling
Laura Gabriela Sanchez-Lozada
Richard J. Johnson
2016 CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
8.0 (11.0), pp. 1472.0-1483.0
127 0 0 0 0 0 127
26. CLINICAL AND PATHOLOGICAL CHARACTERISTICS OF NONDIABETIC RENAL DISEASE IN TYPE 2 DIABETES PATIENTS Kittrawee Kritmetapak
Sirirat Anutrakulchai
Chatlert Pongchaiyakul
Anucha Puapairoj
2016 NEPHROLOGY DIALYSIS TRANSPLANTATION
(31.0), pp. 220.0-220.0
4 0 0 0 0 0 4
27. Factors associated with mortality and high treatment expense of adult patients hospitalized with chronic kidney disease in Thailand Sirirat Anutrakulchai
Cholatip Pongskul
Dhavee Sirivongs
Pantipa Tonsawan
Kaewjai Thepsuthammarat
Sutin Chanaboon
Supannee Promthet
Bandit Thinkhamrop
2016 ASIAN BIOMEDICINE
1.0 (10.0), pp. 15.0-24.0
0 0 0 0 0 0 0
28. Mortality and treatment costs of hospitalized chronic kidney disease patients between the three major health insurance schemes in Thailand Sirirat Anutrakulchai
Pisaln Mairiang
Cholatip Pongskul
Kaewjai Thepsuthammarat
Chitranon Chan-on
Bandit Thinkhamrop
Bandit Thinkhamrop
2016 BMC HEALTH SERVICES RESEARCH
(16.0), pp.
14 0 0 0 0 0 14
29. Mortality and treatment costs of hospitalized chronic kidney disease patients between the three major health insurance schemes in Thailand (vol 16, 528, 2016) Sirirat Anutrakulchai
Pisaln Mairiang
Cholatip Pongskul
Kaewjai Thepsuthammarat
Chitranon Chan-on
Bandit Thinkhamrop
2016 BMC HEALTH SERVICES RESEARCH
(16.0), pp.
0 0 0 0 0 0 0
30. Mortality and treatment costs of hospitalized chronic kidney disease patients between the three major health insurance schemes in Thailand (vol 16, 528, 2016) Sirirat Anutrakulchai
Pisaln Mairiang
Cholatip Pongskul
Kaewjai Thepsuthammarat
Chitranon Chan-on
Bandit Thinkhamrop
2016 BMC HEALTH SERVICES RESEARCH
(16.0), pp.
0 0 0 0 0 0 0
31. Prevalence of insomnia and related impact: An analysis from a university community Manchumad Manjavong
Panita Limpawattana
Pisaln Mairiang
Sirirat Anutrakulchai
2016 INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE
6.0 (51.0), pp. 544.0-553.0
7 0 0 0 0 0 7
32. Relation of peritubular capillary features to class of lupus nephritis Sirirat Anutrakulchai
Tanin Titipungul
Thanyaluk Pattay
Putachart Mesung
Anucha Puapairoj
Dhavee Sirivongs
Cholatip Pongsakul
Prasit Futrakul
Bandit Thinkhamrop
Richard J. Johnson
2016 BMC NEPHROLOGY
(17.0), pp.
0 0 0 0 0 0 0
33. Relation of peritubular capillary features to class of lupus nephritis Sirirat Anutrakulchai
Tanin Titipungul
Thanyaluk Pattay
Putachart Mesung
Anucha Puapairoj
Dhavee Sirivongs
Cholatip Pongsakul
Prasit Futrakul
Bandit Thinkhamrop
Richard J. Johnson
2016 BMC NEPHROLOGY
(17.0), pp.
0 0 0 0 0 0 0
34. Utility of body mass index and neck circumference to screen for metabolic syndrome in Thai people Manchumad Manjavong
Panita Limpawattana
Sornwichate Rattanachaiwong
Pisaln Mairiang
Sirirat Reungjui
2017 ASIAN BIOMEDICINE
1.0 (11.0), pp. 55.0-63.0
4 0 0 0 0 0 4
35. Clinical and pathological characteristics of non-diabetic renal disease in type 2 diabetes patients Kittrawee Kritmetapak
Sirirat Anutrakulchai
Chatlert Pongchaiyakul
Anucha Puapairoj
2018 CLINICAL KIDNEY JOURNAL
3.0 (11.0), pp. 342.0-347.0
6 0 0 0 0 0 6
36. Comparison of disease activity between tacrolimus and mycophenolate mofetil in lupus nephritis: a randomized controlled trial N. Kamanamool
A. Ingsathit
S. Rattanasiri
P. Ngamjanyaporn
N. Kasitanont
R. Chawanasuntorapoj
W. Pichaiwong
S. Anutrakulchai
P. Sangthawan
V. Ophascharoensuk
Y. Avihingsanon
V. Sumethkul
2018 LUPUS
4.0 (27.0), pp. 647.0-656.0
9 0 0 0 0 0 9
37. URINE TWEAK AS A BIOMARKER FOR EARLY RESPONSE TO TREATMENT IN ACTIVE LUPUS NEPHRITIS: A PROSPECTIVE MULTI-CENTER STUDY Thitima Benjachat Suttichet
Api Chewcharat
Wonngarm Kittanamongkolchai
Chutipha Phromjeen
Sirirat Anutrakulchai
Thanachai Panaput
Atiporn Ingsathit
Nanticha Kamanamool
Vuddhidej Ophascharoensuk
Vasant Sumethakul
Yingyos Avihingsanon
2018 NEPHROLOGY DIALYSIS TRANSPLANTATION
(33.0), pp.
0 0 0 0 0 0 0
38. Effect of CYP3A5 genotype on hospitalization cost for kidney transplantation Suda Vannaprasaht
Chulaporn Limwattananon
Sirirat Anutrakulchai
Chitranon Chan-on
2019 INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
1.0 (41.0), pp. 88.0-95.0
0 0 0 0 0 0 0
39. Monosodium Glutamate (MSG) Renders Alkalinizing Properties and Its Urinary Metabolic Markers of MSG Consumption in Rats Kanokwan Nahok
Jia V. Li
Jutarop Phetcharaburanin
Hasina Abdul
Chaisiri Wongkham
Raynoo Thanan
Atit Silsirivanit
Sirirat Anutrakulchai
Carlo Selmi
Ubon Cha'on
2019 BIOMOLECULES
10.0 (9.0), pp.
0 0 0 0 0 0 0
40. Prediction Of Serum Digoxin Concentration Using Estimated Glomerular Filtration Rate In Thai Population Orawan Sae-lim
Thitima Doungngern
Siriluk Jaisue
Sirichai Cheewatanakornkul
Poukwan Arunmanakul
Sirirat Anutrakulchai
Rungsrit Kanjanavanit
Wibul Wongpoowarak
2019 INTERNATIONAL JOURNAL OF GENERAL MEDICINE
(12.0), pp. 455.0-463.0
0 0 0 0 0 0 0
41. Therapeutic concentration achievement and allograft survival comparing usage of conventional tacrolimus doses and CYP3A5 genotype-guided doses in renal transplantation patients Sirirat Anutrakulchai
Cholatip Pongskul
Kittrawee Kritmetapak
Chulaporn Limwattananon
Suda Vannaprasaht
2019 BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
9.0 (85.0), pp. 1964.0-1973.0
1 0 0 0 0 0 1
42. Urine TWEAK level as a biomarker for early response to treatment in active lupus nephritis: a prospective multicentre study Thitima Benjachat Suttichet
Wonngarm Kittanamongkolchai
Chutipha Phromjeen
Sirirat Anutrakulchai
Thanachai Panaput
Atiporn Ingsathit
Nanticha Kamanamool
Vuddhidej Ophascharoensuk
Vasant Sumethaku
Yingyos Avihingsanon
2019 LUPUS SCIENCE & MEDICINE
1.0 (6.0), pp.
1 0 0 0 0 0 1
43. Improved agar plate culture conditions for diagnosis of Strongyloides stercoralis Wannee Kaewrat
Chatchawan Sengthong
Manachai Yingklang
Kitti Intuyod
Ornuma Haonon
Sudarat Onsurathum
Rungtiwa Dangtakot
Phitsamai Saisud
Arunnee Sangka
Sirirat Anutrakulchai
Somchai Pinlaor
Ubon Cha'on
Porntip Pinlaor
2020 ACTA TROPICA
(203.0), pp.
1 0 0 0 0 0 1

Title Authors Year Journal title

ชื่อโครงการ Authors ประเภทโครงการ ปีงบประมาณ ทุนวิจับ

0.01651144027709961